Meduloc LLC receives US patent issuance

October 2020

Meduloc LLC today announced it has received US patent issuance for its novel intramedullary fixation device.  Meduloc’s intermedullary fixation system is designed to treat small, long-bone fractures (fingers, feet, clavicle, radius and ulna).  It provides the surgeon superior fracture reduction, fixation and rotational stability and utilizes a minimally invasive, soft tissue sparing surgical approach. 


Meduloc LLC is one of Cor Medical Ventures’ portfolio companies which is currently raising a $1M seed round of funding to complete the required testing and regulatory approvals needed to bring this technology to the market.


Smith+Nephew expands in higher-growth extremities segment through planned acquisition of Integra LifeSciences' Extremity Orthopaedics business

September 2020


Cor Medical Ventures congratulates Integra and S&N for this mutually beneficial transaction. The team at Cor have been instrumental in the development of several of Integra’s extremity technologies which increased the value of this transaction. Cor is proud to partner with companies like Integra and Smith+Nephew as they advance the care of patients around the world.


Cor Medical Ventures headquarters move to Del Mar, California

August 2020

In order to support our continued growth, Cor Medical Ventures has moved our offices one exit south to:

2010 Jimmy Durante Blvd. Suite 200 Del Mar, CA  


Our new location will feature an expanded prototype machine shop and additive manufacturing lab, along with flexible, open-plan office space.


We are grateful for the opportunity to work with so many great companies, surgeons, and inventors. Despite the challenges and difficulties the medical device industry has faced in 2020, we continue to accelerate product development, clinical studies, and regulatory approvals for our clients.

COVID-19 Update

Cor Medical Ventures continues to support our customers, clients, employees, and the communities in which we work despite the challenges of the pandemic. We have successfully worked to avoid disruptions caused by COVID-19, while at the same time acting responsibly to do what we can to prevent further spread of the virus. We continue to closely monitor and assess the evolving situation and are following all local and federal workplace policies. Our offices are now open at full capacity. We are attending and conducting in-person meetings by following and implementing the required precautions and protections.  We continue conduct virtual meetings as well in order to support the various needs of our customers. 


COR OPEN HOUSE - Del Mar - 8/31/21

Cor Medical Ventures hosted an Open House on September 10th to celebrate the move into our offices and showcase several of our portfolio companies; SimVivo, Tesa Medical, Osteal Therapeutics, Avira, Meduloc, and SAIL Fusion.  Thank you to all who attended and made the evening a great success. 

AAOS - San Diego - 9/1/21

Back in person, Cor Medical Ventures attended the 2021 AAOS meeting held here in our home town of San Diego.  It was great to see all the familiar faces (all be it masked) and many new ones as well.  We showcased several of our key Orthopaedic companies; SAIL Fusion, Meduloc, Delta Ortho, and Spine Innovation.  Thank you to all who stopped by the booth and made the meeting great success. 

NASS - Boston - 9/29/21

Our first big company trip since Covid began has us traveling to Boston to attend the 2021 NASS meeting.  Once again, it was great to see all the familiar faces (all be it masked) and many new ones as well.  We showcased our two key Spine companies; Spine Innovation and SAIL Fusion.  Thank you to all who stopped by the booth and made the meeting great success.